Literature DB >> 32814359

Allovalency observed by transferred NOE: interactions of sulfated tyrosine residues in the N-terminal segment of CCR5 with the CCL5 chemokine.

Naama Kessler1, Sabine R Akabayov1, Adi Moseri1, Leah S Cohen2,3, Damir Sakhapov1, David Bolton4, Brandon Fridman2, Lewis E Kay5,6,7,8, Fred Naider2,3, Jacob Anglister1.   

Abstract

The N-terminal segment of the chemokine receptor Human CC chemokine receptor 5 (CCR5), Nt-CCR5, contains four tyrosine residues, Y3, Y10, Y14, and Y15. Sulfation of at least two of these tyrosine residues was found to be essential for high-affinity binding of CCR5 to its chemokine ligands. Here, we show that among the monosulfated Nt-CCR5(8-20) peptide surrogates (sNt-CCR5) those sulfated at Y15 and Y14 have the highest affinity for the CC chemokine ligand 5 (CCL5) chemokine in comparison with monosulfation at position Y10. Sulfation at Y3 was not investigated. A peptide sulfated at both Y14 and Y15 has the highest affinity for CCL5 by up to a factor of 3, in comparison with the other disulfated (sNt-CCR5) peptides. Chemical shift perturbation analysis and transferred nuclear Overhauser effect measurements indicate that the sulfated tyrosine residues interact with the same CCL5-binding pocket and that each of the sulfated tyrosines at positions 10, 14, and 15 can occupy individually the binding site on CCL5 in a similar manner, although with somewhat different affinity, suggesting the possibility of allovalency in sulfated Nt-CCR5 peptides. The affinity of the disulfated peptides to CCL5 could be increased by this allovalency and by stronger electrostatic interactions.
© 2020 Federation of European Biochemical Societies.

Entities:  

Keywords:  CCL5; CCR5; chemokines; intermolecular interactions; sulfated tyrosine; transferred NOE

Year:  2020        PMID: 32814359     DOI: 10.1111/febs.15503

Source DB:  PubMed          Journal:  FEBS J        ISSN: 1742-464X            Impact factor:   5.542


  1 in total

1.  Structural basis of the activation of the CC chemokine receptor 5 by a chemokine agonist.

Authors:  Polina Isaikina; Ching-Ju Tsai; Nikolaus Dietz; Filip Pamula; Anne Grahl; Kenneth N Goldie; Ramon Guixà-González; Camila Branco; Marianne Paolini-Bertrand; Nicolas Calo; Fabrice Cerini; Gebhard F X Schertler; Oliver Hartley; Henning Stahlberg; Timm Maier; Xavier Deupi; Stephan Grzesiek
Journal:  Sci Adv       Date:  2021-06-16       Impact factor: 14.136

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.